2022 POSTER PRESENTATIONS
P01: Affinity Separation Powered by Nanofitins, Presented by Anne C., Affilogic
P02: Bioprocess Product for Protein Purification: BioOptimal™ MF-SL, Presented by Achraf J., Asahi Kasei Bioprocess Europe S.A.
P03: Fully Automated Droplet Screening of Cells and Biomolecules High Throughput Screening for Cell Line and Microbial Strain Development, Presented by Thomas H., Efficient Robotics GmbH
P04: High-Throughput, Automated Analysis of Viral Vector Titer and Process Related Impurities Accelerates Downstream Process Development of AAV Based Gene Therapies, Presented by Jose M., Gyros Protein Technologies
P05: Aura+: High Throughput, Low Volume Product Stability and Purity Analysis for Gene and Cell Therapies, Presented by Paul D., Halo Labs
P06: High Throughput, Low Volume Subvisible Particle Analysis of Adeno-Associated Viruses, Presented by Paul D., Halo Labs
P07: Model-Based Intensification of AAV Production in Insect Cells, Presented by Cristina R., iBET - Instituto de Biologia Experimental e Tecnologica
P08: Evaluation of an Online PAT Co-Laboratory for Rapid Process Development, Presented by Jens P., Lonza Walkersville, Inc.
P09: Construction of InstantPC-Derivatized N-Glycan GU Database for High-Throughput and High Sensitivity Glycosylation Profiling, Presented by Michael B., National Institute for Bioprocessing Research and Training (NIBRT)
P10: Automated Protein A-Protein L Purification of scFvs Using an ÄKTA Pure Coupled to a Teledyne CETAC ASX-560 Autosampler, Presented by Bastian F., Numab Therapeutics AG
P11: Empty and Full Separation of Adeno-Associated Virus Vectors by Anion Exchange Membrane Chromatography, Presented by Xenia M., Pall Corporation
P12: Downstream Purification: A Toolbox Approach for Adaptive Multi-Serotype AAV Solutions, Presented by Gareth B., Pharmaron
P13: Next-Generation Transfection Reagent for Large Scale AAV Manufacturing, Presented by Jelena V., Polyplus-transfection
P14: Adaptive Feed Control Based on a Predictive Glucose Model, Presented by Marcus K., Qubicon AG
P15: Central Data Management and Model-Based Cross-Device Process Control, Presented by Wolfgang S., Qubicon AG
P16: Achieving Single-Cell Resolution for Cytokine Secretion and Cell Killing Assays with Xdrop®, Presented by Marie M., Samplix ApS
P17: Targeted and Accurate Assessments of Gene Editing Outcomes in Engineered Cell Therapy with Xdrop® and Long-Read Sequencing, Presented by Peter M., Samplix ApS
P18: Boosting Monoclonal Antibody Productivity of Fed-Batch Processes by Recovering Viable Cells, Presented by Lucas R., Sartorius AG
P19: Intensifying Cell Clarification by Fluidized Bed Centrifugation with Integrated Filtration, Presented by Martin S., Sartorius AG
P20: Optimized Combination of Regulatory Elements Enhancing mAb Production, Presented by Sandrine C., Sartorius Stedim Cellca GmbH
P21: Clean CHO - Engineering CHO DG44 Cell Lines Towards a Reduced Host Cell Protein Profile, Presented by Daniela K., Sartorius Stedim Cellca GmbH
P22: On-Line Metabolomics for Bioprocess Monitoring, Presented by Joan C., University of Edinburgh
P23: Applications of a Real-Time, Optical Technique for Quantifying Proteins Directly Within Mixtures, Presented by John H., University College London
P24: Creating a 'Plug & Play' Vector System for the Generation of Engineered Exosomes as a Novel Vaccine Platform, Presented by Laura D., University of Kent
P25: Online Model-Based Control and Optimization of Protein Purification in Liquid Chromatography, Presented by Touraj E., University of Natural Resources and Applied Life Sciences (BOKU)
P26: Rapid and High-Throughput Assay for IgG Quantification in Cell Culture Supernatant for Cell Line Development, Presented by Eligio I., ValitaCell Ltd.
P27: ChemStress® CHO MediaQC Tool to Assess Media Variation by Cell Profiling, Presented by Alessandra P., ValitaCell Ltd.
P28: ChemStress® CHO Profiling Technology to Monitor Deep Cell Function in Clone Stability Trial, Presented by Alessandra P., ValitaCell Ltd.
P29: Visualization and Robust Quantitative TEM Analyses for Gene Therapy Products, Presented by Beata H., Vironova AB
P30: Robotics and Miniaturization Enable Fast Serotype Adaptation of AAV DSP Platform, Presented by Andreas M., Baxalta Innovations GmbH, a part of Takeda
P31: Two-Step Monoclonal Antibody Purification Approach Using Mixed-Mode Chromatography, Presented by Jean-Francois D., Bio-Rad Laboratories
P32: Purification of Single-Stranded Oligonucleotides Using AEX Chromatography Resin, Presented by Artur S., Bio-Rad Laboratories
P33: Manufactural Process Development of a Novel Collagen-Targeted Protein MRI Contrast Agent, Presented by Dongjun L., Georgia State University
P34: Robust Clarification of the High-Titer, Low-Cost C1 Fungal Expression System Using the Cationic Flocculant pDADMAC, Presented by Stephen C., Merck Life Science UK Ltd.
P35: Evaluation of Plasmid Modifications Effects on Monoclonal Antibody Productivity, Presented by Katarzyna S., Merck Serono SA
P36: Raman Based Chemometric Model Development for Glycation and Glycosylation Profile Monitoring in a CHO Cell Bioreactor Process at Reduced and Manufacturing Scale, Presented by Luke G., Munster Technological University
P37: A Systematic, Model-Based Workflow for Risk-Based Decision Making in Upstream Development, Presented by Tanja H., Ostwestfalen-Lippe University of Applied Sciences and Arts